Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

2.
3.

[Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].

Azevedo LL, Cardoso F, Reis C.

Arq Neuropsiquiatr. 2003 Dec;61(4):999-1003. Portuguese.

4.

Comparison of two forms of intensive speech treatment for Parkinson disease.

Ramig LO, Countryman S, Thompson LL, Horii Y.

J Speech Hear Res. 1995 Dec;38(6):1232-51.

PMID:
8747817
5.

Aerodynamic and acoustic voice measurements of patients with vocal nodules: variation in baseline and changes across voice therapy.

Holmberg EB, Doyle P, Perkell JS, Hammarberg B, Hillman RE.

J Voice. 2003 Sep;17(3):269-82.

PMID:
14513951
6.

Investigation of the immediate effects of two semi-ocluded vocal tract exercises.

Sampaio M, Oliveira G, Behlau M.

Pro Fono. 2008 Oct-Dec;20(4):261-6.

7.

Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.

Kempler D, Van Lancker D.

Brain Lang. 2002 Mar;80(3):449-64.

PMID:
11896652
8.

Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.

Di Benedetto P, Cavazzon M, Mondolo F, Rugiu G, Peratoner A, Biasutti E.

Eur J Phys Rehabil Med. 2009 Mar;45(1):13-9.

9.

[Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].

Azevedo LL, Cardoso F, Reis C.

Arq Neuropsiquiatr. 2003 Dec;61(4):995-8. Portuguese.

10.

Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.

Hartelius L, Svantesson P, Hedlund A, Holmberg B, Revesz D, Thorlin T.

Folia Phoniatr Logop. 2010;62(3):104-9. doi: 10.1159/000287208.

PMID:
20424465
11.
12.

[Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].

Dias AE, Limongi JC.

Arq Neuropsiquiatr. 2003 Mar;61(1):61-6. Portuguese.

13.

Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease.

Neel AT.

J Speech Lang Hear Res. 2009 Aug;52(4):1021-33. doi: 10.1044/1092-4388(2008/08-0119).

PMID:
18978211
14.

Voice and speech of individuals with Parkinson s Disease during amplification, delay and masking situations.

Coutinho SB, Diaféria G, Oliveira G, Behlau M.

Pro Fono. 2009 Jul-Sep;21(3):219-24.

15.

Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.

Sapir S, Spielman JL, Ramig LO, Story BH, Fox C.

J Speech Lang Hear Res. 2007 Aug;50(4):899-912. Erratum in: J Speech Lang Hear Res. 2007 Dec;50(6):1652.

PMID:
17675595
16.

The effect of group music therapy on mood, speech, and singing in individuals with Parkinson's disease--a feasibility study.

Elefant C, Baker FA, Lotan M, Lagesen SK, Skeie GO.

J Music Ther. 2012 Autumn;49(3):278-302.

PMID:
23259231
17.

The effect of levodopa on vocal function in Parkinson's disease.

Sanabria J, Ruiz PG, Gutierrez R, Marquez F, Escobar P, Gentil M, Cenjor C.

Clin Neuropharmacol. 2001 Mar-Apr;24(2):99-102.

PMID:
11307045
18.

Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.

D'Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR.

J Voice. 2008 May;22(3):365-72.

PMID:
17368837
19.

Assessing vocal function after chemoradiation for advanced laryngeal carcinoma.

Woodson GE, Rosen CA, Murry T, Madasu R, Wong F, Hengesteg A, Robbins KT.

Arch Otolaryngol Head Neck Surg. 1996 Aug;122(8):858-64.

PMID:
8703390
20.

Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.

Weismer G, Jeng JY, Laures JS, Kent RD, Kent JF.

Folia Phoniatr Logop. 2001 Jan-Feb;53(1):1-18.

PMID:
11125256
Items per page

Supplemental Content

Support Center